SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-10-021646
Filing Date
2010-04-22
Accepted
2010-04-22 12:21:04
Documents
8
Period of Report
2010-04-17
Filing Date Changed
2010-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v181907_8k.htm 8-K 31145
2 v181907_ex10-1.htm EX-10.1 1075495
3 GRAPHIC e1pg01.jpg GRAPHIC 328575
4 GRAPHIC e1pg02.jpg GRAPHIC 286893
5 GRAPHIC e1pg03.jpg GRAPHIC 330133
6 GRAPHIC e1pg04.jpg GRAPHIC 397189
7 GRAPHIC e1pg05.jpg GRAPHIC 380881
8 GRAPHIC e1pg06.jpg GRAPHIC 185592
  Complete submission text file 0001144204-10-021646.txt   3739774
Mailing Address 243 CRANFIELD GREEN SE CALGARY A0 T3M 1C4
Business Address 243 CRANFIELD GREEN SE CALGARY A0 T3M 1C4 403-370-1176
Kun Run Biotechnology, Inc. (Filer) CIK: 0001393526 (see all company filings)

IRS No.: 980517550 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53621 | Film No.: 10763807
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1